These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 6209204)

  • 1. Migration inhibition factor secreting human T-cell lines reactive to PPD: a study of their antigen specificity, MHC restriction and the use of Epstein-Barr virus-transformed B-cell lines as requirement for antigen-presenting cells.
    Vyakarnam A; Lachmann PJ
    Immunology; 1984 Dec; 53(4):601-10. PubMed ID: 6209204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DR-, MB- and novel DC-related determinants restrict purified protein derivative of tuberculin (PPD)-stimulated human T cell proliferation.
    Pawelec G; Schneider EM; Müller C; Wernet P
    Eur J Immunol; 1985 Jan; 15(1):12-7. PubMed ID: 2578396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parasite antigen-specific human T cell lines and clones. Major histocompatibility complex restriction and B cell helper function.
    Nutman TB; Ottesen EA; Fauci AS; Volkman DJ
    J Clin Invest; 1984 Jun; 73(6):1754-62. PubMed ID: 6233302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of three PPD-reactive helper T cell clones with distinct functions in B cell activation.
    Sano Y; Yamada G; Dobashi K; Mizuochi T; Hamaoka T; Takatsu K
    J Immunol; 1984 Aug; 133(2):629-35. PubMed ID: 6234353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T-cell hybrids with HLA-restricted proliferative response to Epstein-Barr virus-infected B cells.
    Gallagher G; Stimson WH
    Immunology; 1984 Dec; 53(4):611-21. PubMed ID: 6209205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid cells formed by fusion of Epstein-Barr virus-associated B-lymphoblastoid cells and either marrow-derived or solid tumour-derived cell lines display different co-stimulatory phenotypes and abilities to activate allogeneic T-cell responses in vitro.
    Cywinski AL; Dunnion DJ; Teobald I; Tucker VC; Browning MJ
    Tissue Antigens; 2006 Aug; 68(2):115-26. PubMed ID: 16866881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloantigen presentation by B cells: analysis of the requirement for B-cell activation.
    Wilson JL; Cunningham AC; Kirby JA
    Immunology; 1995 Nov; 86(3):325-30. PubMed ID: 8550066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific B lymphocytes efficiently pick up, process and present antigen to T cells.
    Lanzavecchia A; Bove S
    Behring Inst Mitt; 1985 Aug; (77):82-7. PubMed ID: 3002320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of antigen-specific and MHC-restricted B cell hybridoma clones: a model for studying antigen presentation to T cell lines and clones.
    Zimecki M; Kapp JA; Pierce CW
    Arch Immunol Ther Exp (Warsz); 1988; 36(4):395-408. PubMed ID: 2471476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of monoclonal antibodies to an EBV transformed B-cell line.
    Schröder J; Suomalainen HA; Parkkinen E; Lundqvist C; Wada G; Koskimies S
    Med Biol; 1982 Oct; 60(5):255-9. PubMed ID: 6296556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones.
    Schnyder B; Mauri-Hellweg D; Zanni M; Bettens F; Pichler WJ
    J Clin Invest; 1997 Jul; 100(1):136-41. PubMed ID: 9202065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen presentation by EBV-B cells to resting and activated T cells: role of interleukin 1.
    Chu ET; Lareau M; Rosenwasser LJ; Dinarello CA; Geha RS
    J Immunol; 1985 Mar; 134(3):1676-81. PubMed ID: 2981918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T lymphocyte culture established by repeated stimulation with the autologous lymphoblastoid line. MHC class II restricted interactions with B blasts.
    Torsteinsdottir S; Masucci MG; Szigeti R; Bishara A; Brautbar C; Klein G; Klein E
    Mol Biol Med; 1984 Aug; 2(4):285-99. PubMed ID: 6443579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell clones restricted to "hybrid" HLA-D antigens?
    Hansen GS; Svejgaard A; Claësson MH
    J Immunol; 1982 Jun; 128(6):2497-9. PubMed ID: 6176640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining MHC restriction of T-cell responses.
    Larché M
    Methods Mol Med; 2008; 138():57-72. PubMed ID: 18615244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human antigen-specific T hybridomas.
    DeFreitas EC
    Behring Inst Mitt; 1985 Aug; (77):68-74. PubMed ID: 3002319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide-induced T cell clones: specificity, MHC restriction, proliferation and cytokine pattern as a function of different stimulations.
    Pichler WJ; Brander C; Mauri D; Frutig K; Wyss-Coray T
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1994; (87):141-53; discussion 153-4. PubMed ID: 7873053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncytotoxic human CD4+ T-cell clones presenting and simultaneously responding to an antigen die of apoptosis.
    Bettens F; Frei E; Frutig K; Mauri D; Pichler WJ; Wyss-Coray T
    Cell Immunol; 1995 Mar; 161(1):72-8. PubMed ID: 7532549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of autologous CD4- and CD8-mediated T-cell responses against acute lymphocytic leukemia cell line using apoptotic tumor cell-loaded dendritic cells.
    Hatakeyama N; Tamura Y; Sahara H; Suzuki N; Suzuki K; Hori T; Mizue N; Torigoe T; Tsutsumi H; Sato N
    Exp Hematol; 2006 Feb; 34(2):197-207. PubMed ID: 16459188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.